Kexing Biopharm Co., Ltd.SSE: 688136

SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

· Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/shan-dong-kexing-bioproducts-co-ltdspecial-report-on-the-deposit-management-and-actual-use-of-raised-funds-for-the-first-half-of-2026

Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Kexing Biopharm Co., Ltd. on 6ix

Story so far

Earlier from Kexing Biopharm

Later from Kexing Biopharm

All Kexing Biopharm news releases